DNMT1 regulated the DNA methylation in the promoter region of miR-211, decreased the expression level of miR-211 in melanoma cells and increased the expression level of its downstream target gene RAB22A, thus promoting the EMT process [18]. The gene discussed is RAB22A; the disease is melanoma.